Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
iBio, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
iBio, Inc.Listing on record | Sell | $28.4M | SEC | ||
iBio, Inc.Listing on record | Sell | $46.3M | SEC | ||
iBio, Inc.Listing on record | Sell | $5.2M | SEC | ||
iBio, Inc.Listing on record | Other | $5.8M | SEC | ||
iBio, Inc.Listing on record | Buy | $2M | conv 51 | SEC | |
iBio, Inc.Listing on record | Buy | $2.4M | conv 49 | SEC | |
Bio Green Med Solution, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC | |
Bio Green Med Solution, Inc.Listing unverified | Buy | $1.7M | conv 64First in 12mo | SEC | |
Marker Therapeutics, Inc.Listing on record | Other | $2M | SEC | ||
Marker Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Marker Therapeutics, Inc.Listing on record | Other | $2.5M | SEC | ||
Marker Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
iBio, Inc.Listing on record | Buy | n/a (No price was disclosed in the filing) | conv 55First in 12mo | SEC | |
iBio, Inc.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |